New Acute Lymphoblastic Leukemia Findings from Peking University Institute of Hematology Described (Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs)

Press/Media: Press / Media

PeriodDec 25 2024

Media coverage

1

Media coverage

  • TitleNew Acute Lymphoblastic Leukemia Findings from Peking University Institute of Hematology Described (Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date12/25/24
    PersonsJing Li